The global custom procedure kits market size is calculated at USD 8.96 billion in 2024, grew to USD 10.06 billion in 2025, and is predicted to hit around USD 28.62 billion by 2034, poised to grow at a CAGR of 12.3% between 2024 and 2034. The North America custom procedure kits market size accounted for USD 4.12 billion in 2024 and is anticipated to grow at the fastest CAGR of 12.44% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Custom Procedure Kits Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Custom Procedure Kits Market Revenue and Volume, by Product, 2024-2034
8.1.1 Disposable
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Reusable
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Custom Procedure Kits Market Revenue and Volume, by Procedure, 2024-2034
9.1.1. Colorectal
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Thoracic
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Orthopedic
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Ophthalmology
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Neurosurgery
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1.6. Cardiac Surgery
9.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1.7. Gynecology
9.1.7.1. Market Revenue and Volume Forecast (2021-2034)
9.1.8. Others
9.1.8.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Custom Procedure Kits Market Revenue and Volume, by End User, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Clinics
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End User (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1. Medline Industries, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Teleflex Incorporated
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Boston Scientific Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. BD (Becton, Dickinson and Company)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Owens & Minor, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. 3M
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Mölnlycke Health Care
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Cardinal Health, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. B. Braun Melsungen AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Halyard Health, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample